Viridian Therapeutics (VRDN) Stock Posts Double-Digit Growth Year-on-Year

In March, Viridian Therapeutics announced affirmative topline information from the elegrobart REVEAL-1 signifier 3 objective proceedings successful patients with progressive thyroid oculus illness (TED). Elegrobart is simply a subcutaneously delivered, half-life-extended monoclonal antibody targeting the insulin-like maturation factor-1 receptor (IGF-1R). REVEAL-1 evaluated 2 dosing regimens, each 4 weeks (Q4W) and each 8 weeks (Q8W), compared with placebo.

Viridian Therapeutics President and Chief Executive Officer Steve Mahoney expressed excitement successful reporting the results. In a statement, helium said:

“REVEAL-1 met its superior endpoint with precocious statistical significance. Elegrobart attraction drove robust proptosis responses successful a attraction regimen comprised of arsenic fewer arsenic 3 subcutaneous doses. Further, successful the Q4W arm, we saw clinically meaningful diplopia responses and diplopia resolution. Currently, the lone marketed attraction for TED requires 8 intravenous infusions and, contempt debased marketplace penetration, annualized successful 2025 to astir $2B successful revenues. We judge determination is simply a important accidental with subcutaneous elegrobart successful TED, including the imaginable to grow the marketplace arsenic an at-home and self-administered attraction option, if approved.”

Viridian Therapeutics, Inc. (NASDAQ:VRDN) is simply a biopharmaceutical institution focused connected discovering, developing, and commercializing imaginable best-in-class medicines for patients with superior and uncommon diseases. The company’s expertise successful antibody find and macromolecule engineering enables the improvement of differentiated therapeutic candidates for validated cause targets and disease-driving mechanisms successful autoimmune and uncommon diseases.

While we admit the imaginable of VRDN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Data Center Stocks to Buy for the Long Term and 8 Must-Buy Small Cap Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.